Gamma-Glu-Val-Gly Fermentation via tdh/kbl-Engineered Enterobacteriaceae
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing the tripeptide γ-Glu-Val-Gly are inefficient and have not utilized fermentation of microorganisms, despite its desirable applications in the food and fragrance industries.
Innovation Solution
A method involving the cultivation of a modified bacterium from the Enterobacteriaceae family that overexpresses the tdh and kbl genes, encoding proteins with L-threonine 3-dehydrogenase and 2-amino-3-oxobutanoate coenzyme A ligase activities, to produce and accumulate γ-Glu-Val-Gly in the culture medium or bacterial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional chemical and enzymatic methods are used to produce γ-Glu-Val-Gly, then the tripeptide can be synthesized, but the production efficiency is low and the process is complex
Solution Approach 1:
The patent replaces complex chemical and enzymatic synthesis methods with a biological fermentation system using engineered bacteria. The bacterial cells naturally produce the tripeptide through metabolic pathways, eliminating the need for multiple chemical steps and enzymes, thereby simplifying the process and improving efficiency
Solution Approach 2:
The patent modifies bacterial strains by overexpressing specific genes (tdh and kbl) to change their metabolic parameters. This genetic modification enables the bacteria to produce γ-Glu-Val-Gly at high efficiency, transforming the production process from low-efficiency chemical synthesis to high-efficiency biological synthesis
2Reliability
If mutant microorganisms are created through mutagenesis treatment, then desired strains can be selected, but the process is time-consuming and complex
Solution Approach 1:
The patent performs preliminary genetic engineering by introducing and overexpressing the tdh and kbl genes in the bacterial strain before fermentation. This preliminary action ensures that the bacteria are pre-equipped with the necessary enzymatic machinery to produce γ-Glu-Val-Gly efficiently, eliminating the need for time-consuming mutagenesis screening
Solution Approach 2:
The patent uses genetic engineering to copy and amplify specific functional genes (tdh and kbl) from source organisms into the production bacteria. This copying approach allows direct acquisition of desired traits without random mutagenesis, significantly reducing strain development time while maintaining reliability
3Productivity
If the bacterium is modified to overexpress tdh and kbl genes, then γ-Glu-Val-Gly production is enhanced, but the genetic modification process becomes more complex
Solution Approach 1:
The patent merges the overexpression of multiple genes (tdh and kbl) into a single bacterial strain through coordinated genetic engineering. By combining these functional elements in one organism, the patent achieves high tripeptide production without requiring multiple separate modification steps or complex multi-step processes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient production of γ-Glu-Val-Gly, achieving accumulation levels greater than non-modified strains, facilitating its collection and utilization in food and fragrance industries.
Implementation Method 1
a method for producing a tripeptide, and more specifically, the tripeptide γ-Glu-Val-Gly, by fermentation of a bacterium
Data Source
AI summary
A method for producing γ-Glu-Val-Gly is described, wherein the method includes the steps of cultivating a γ-Glu-Val-Gly-producing bacterium belonging to the family Enterobacteriaceae in a culture medium so that the γ-Glu-Val-Gly accumulates in the culture medium or the cells of the bacterium, or both, and collecting the γ-Glu-Val-Gly from the culture medium or the cells of the bacterium, or both. The bacterium has been modified to overexpress a gene encoding a protein having L-threonine 3-dehydrogenase activity and a gene encoding a protein having 2-amino-3-oxobutanoate coenzyme A ligase activity.